Arsanis, Inc. (ASNS)


Arsanis, Inc. (ASNS)

$3.11 USD

0.13 (-3.86%)

Updated Mar 13 7:48pm

Add ASNS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

ASNS Daily Price Range
ASNS 52-Week Price Range

ASNS News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All ASNS News

Arsanis, Inc. (ASNS) Company Bio


Arsanis, Inc., a clinical-stage biopharmaceutical company, focuses on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. Its lead product candidate is ASN100, a first-in-class mAb therapeutic in Phase II clinical development for the prevention of staphylococcus aureus pneumonia. The company’s preclinical pipeline comprises mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus. Arsanis, Inc. was founded in 2010 and is based in Waltham, Massachusetts.

ASNS Stock Chart More Charts


ASNS Price/Volume Stats

Current price $3.11
Prev. close $3.23
Day low $3.05
Day high $3.78
50-day MA $2.99
200-day MA $4.17
52-week high $28.69
52-week low $1.15
Volume 607,200
Avg. volume 164,537
Dividend yield N/A
Market Cap 45.54M

ASNS Social Stream


Loading social stream, please wait...

View Full ASNS Social Stream

ASNS Returns

1-mo N/A
3-mo N/A
6-mo -0.32%
1-year 2.64%
3-year N/A
5-year N/A
YTD 34.05%
2018 -81.82%
2017 N/A
2016 N/A
2015 N/A
2014 N/A


Page generated in 0.5342 seconds.